Gina Drobena

Associate Professor

UAMS

Also affiliated: Arkansas Children's Hospital (2015); American Red Cross (2017)

Pathology, College of Medicine

3 h-index 11 pubs 18 cited

Research Areas

Biomedical Subjects

Links

ORCID UAMS TRI Profile

OverviewAI-generated summary

Gina Drobena's research focuses on various aspects of blood disorders and treatments, particularly within the context of hematopoietic stem cell transplantation and transfusion medicine. Her work investigates patient outcomes, diagnostic challenges, and therapeutic strategies. Recent publications include studies on hemoglobin variants in pediatric sickle cell disease patients, the efficacy of therapeutic plasma exchange, and the management of heparin-induced thrombocytopenia. She has also examined factors affecting CD34+ cell collection yield in multiple myeloma patients undergoing autologous transplantation and explored challenges in maintaining the quality of bone marrow harvest bags. Drobena collaborates with researchers at the University of Arkansas for Medical Sciences, including Michele Cottler-Fox, H. McAloon, Mayumi Nakagawa, and Nancy Green, with whom she shares multiple publications.

Metrics

h-index: 3
Publications: 11
Citations: 18

Positions

Associate Professor 2008–present

University of Arkansas for Medical Sciences Pathology, College of Medicine Institutional directory

Selected Publications

Post‐transport macroscopic aggregates in a filtered bone marrow harvest bag (2026)

Transfusion DOI OpenAlex
Collection of autologous CD34+ hematopoietic progenitor cells (HPC) in multiple myeloma: CD34 + cell collection yield in relation to molecular subtype, karyotype, and FISH results (2026)

PLoS ONE DOI OpenAlex
A ROADMAP FOR LARGE-SCALE CELLULAR THERAPY PRODUCT DISPOSAL (2026)

Cytotherapy DOI OpenAlex
Impact of New Hematopoietic Progenitor Cell Collection Goals on Apheresis and Cell Therapy Laboratory Services (2025)

Journal of Clinical Apheresis DOI OpenAlex
AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL (HPC) BOOSTS AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY: IMPACT ON THE CELL THERAPY LABORATORY AND STORAGE FACILITY (2025)

Cytotherapy DOI OpenAlex
Antidote Worse Than the Poison? Emergent Therapeutic Plasma Exchange After Overzealous Intravenous Lipid Emulsion Infusion During Treatment of Local Anesthetic Systemic Toxicity (2025)

Journal of Clinical Apheresis 3 citations DOI OpenAlex
SMALL CHANGES, BIG SAVINGS: IMPACT OF HEMATOPOIETIC PROGENITOR CELLS APHERESIS COLLECTION GOALS ON THE CELL THERAPY LAB (2024)

Cytotherapy DOI OpenAlex
Plasma failing visual inspection (2017)

Journal of Clinical Apheresis 2 citations DOI OpenAlex
Utility of Fluorescence Cytometric Cross-Matched Platelets in Severely Alloimmunized Patients (2016)

Blood DOI OpenAlex
Flow Cytometric Panel-Reactive Antibody Results and the Ability to Find Transfusion-Compatible Platelets after Antibody-Desensitization for Allogeneic Bone Marrow Transplant. (2016)

PubMed 3 citations OpenAlex
Heparin‐induced thrombocytopenia: a cautionary tale (2015)

Transfusion 3 citations DOI OpenAlex